China’s Pharmaceutical Industry - Porter’s Five Forces Strategy Analysis - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Jul 6, 2018--The “China’s Pharmaceutical Industry - Porter s Five Forces Strategy Analysis” report has been added to ResearchAndMarkets.com’s offering.
The publisher analyzes China’s Pharmaceutical Industry in the Michael Porter’s Five Forces Analysis.
It uses concepts developed in Industrial Organization (IO) economics to derive five forces that determine the competitive intensity and therefore attractiveness of a market.
Pharmaceutical is one of the most intense Knowledge Driven industries, which is continually in a state of dynamic transition. Diversities in life forms and diseases pose stiff challenge to the design of specific and targeted solutions.
The process of drug discovery/invention is elaborate requiring on an average 8-10 years at a cost of US$ 300 million to reach a new drug to the market.
Key Topics Covered:
A. Executive Summary
B. Introduction to the Industry
C. Porter’s Five Forces Strategy Analysis
E. Glossary of Terms
For more information about this report visit https://www.researchandmarkets.com/research/s2qmgj/chinas?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180706005191/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD: ASIA PACIFIC CHINA
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 07/06/2018 08:59 AM/DISC: 07/06/2018 08:59 AM